Aclaris Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference
Aclaris Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit .WAYNE, Pa., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the Aclaris management team will participate in a fireside chat during the 2024 Cantor Global Healthcare Conference on Tuesday, September 17, 2024 at 8:00 AM ET in New York, New York.
賓夕法尼亞州韋恩，2024年9月10日（GLOBE NEWSWIRE）——專注於開發免疫炎症性疾病新候選藥物的臨床階段生物製藥公司Aclaris Therapeutics, Inc.（納斯達克股票代碼：ACRS）今天宣佈，Aclaris管理團隊成員將在美國東部時間2024年9月17日星期二上午8點參加2024年Cantor全球醫療保健會議期間的爐邊談話紐約，紐約。
A webcast of the fireside chat may be accessed through the "Events" page of the "Investors" section of Aclaris' website, . The webcast will be archived for at least 30 days on the Aclaris website.
可以通過Aclaris網站 「投資者」 部分的 「活動」 頁面訪問爐邊聊天的網絡直播,.該網絡直播將在Aclaris網站上存檔至少30天。
About Aclaris Therapeutics, Inc.
關於 Aclaris Therapeutics, Inc
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit .
Aclaris Therapeutics, Inc. 是一家處於臨床階段的生物製藥公司，正在開發一系列新的候選藥物，以滿足缺乏令人滿意的治療選擇的免疫炎性疾病患者的需求。該公司擁有多階段候選藥物組合，由探索蛋白激酶調節的強大研發引擎提供支持。如需更多信息，請訪問。
Aclaris Therapeutics Contact:
Aclaris 治療聯繫人：
investors@aclaristx.com
investors@aclaristx.com
譯文內容由第三人軟體翻譯。